A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

OBJECTIVES: Treatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The aim of this trial was to assess the possibility of discontinuing treatment with adalimumab (ADA) while maintaining remission in patients wit...

全面介紹

Na minha lista:
書目詳細資料
發表在:RMD Open
Main Authors: Chatzidionysiou, Katerina, Turesson, Carl, Teleman, Annika, Knight, Ann, Lindqvist, Elisabet, Larsson, Per, Cöster, Lars, Forslind, Kristina, van Vollenhoven, Ronald, Heimbürger, Mikael
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2016
主題:
Rheumatoid Arthritis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716561/
https://ncbi.nlm.nih.gov/pubmed/26819752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000133
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍